Dr. Jonathan Spagnola

Ajay J. Kirtane, MD, SM, is the Director of Columbia Interventional Cardiovascular Care and Professor of Medicine at Columbia University Irving Medical Center. He is an internationally-renowned leader in the field of Interventional Cardiology, with a particular focus on providing exceptional and evidence-based care to patients with complex coronary and peripheral vascular disease. In addition to his clinical commitments, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Division of Cardiology, and as director of several international, national, and regional educational conferences in Interventional Cardiovascular Medicine. Dr. Kirtane’s research interests are in clinical trials and outcomes of device-based and pharmacologic interventions to help patients with cardiovascular disease. He is/has been Principal Investigator and serves on the steering committees of numerous clinical trials in interventional cardiovascular medicine and has authored over 700 peer-reviewed publications.Born in Brooklyn, New York, and raised in Bergen County, New Jersey, Dr. Kirtane is a graduate of Ridgewood High School, Princeton University, and Columbia University College of Physicians and Surgeons, and completed his residency/chief residency in Internal Medicine at the University of California – San Francisco. He then completed fellowships in Cardiovascular Disease and Coronary and Peripheral Vascular Intervention at Beth Israel Deaconess Medical Center / Harvard Medical School and additionally obtained a Masters of Science in Clinical Epidemiology from the Harvard School of Public Health prior to moving back to Columbia. In his free time, Dr. Kirtane has avid interests in music and sports, and lives in New Jersey with his family. Dr. Kirtane is highly rated in 26 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Heart Attack, Aortic Valve Stenosis, Percutaneous Coronary Intervention (PCI), and Atherectomy.

An internationally recognized leader in structural heart disease, Dr. Généreux has been a practicing interventional cardiologist for more than 15 years. He is the director of the structural heart program at Morristown Medical Center, has served as the primary or co-investigator on more than 20 clinical trials, and has published more than 350 articles in peer-reviewed journals. He is currently the principal investigator of the EARLY TAVR trial and the PROGRESS trial, two major studies in the field of aortic valve disease. A celebrated clinical researcher since the beginning of his career, he was awarded the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and has been named a Highly Cited Researcher by the Clarivate™ Web of Science™ Group for the last four years. Dr. Généreux is also involved in multiple early-stage companies in the field of interventional cardiology and heart failure. He received his medical degree from the Université de Montréal, Montréal, Québec, Canada, his cardiology and interventional cardiology degrees from Université de Sherbrooke and Sacré-Coeur Hospital, Montreal, Canada, and performed his advanced interventional cardiology and structural heart fellowship at Columbia University and Cardiovascular Research Foundation, in New York city. Dr. Genereux is highly rated in 17 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Coronary Heart Disease, Aortic Valve Replacement, and Percutaneous Coronary Intervention (PCI).

Martin Leon is a Cardiologist and an Interventional Cardiologist in New York, New York. Dr. Leon is highly rated in 27 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Tricuspid Regurgitation, Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Leon is currently accepting new patients.